Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Bayer, Schering-Plough deal

SGP acquired exclusive rights to market, sell and distribute in the U.S. and Puerto Rico certain primary healthcare products from Bayer Healthcare, a unit of BAYG. The products include antibiotics Avelox moxifloxacin and

Read the full 338 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE